tradingkey.logo

US govt looks to bring 'greater transparency' for drug price negotiation program

ReutersJan 29, 2025 1:10 PM

- The U.S. government will consider opportunities to "bring greater transparency" for the Medicare drug price negotiation program under President Donald Trump's administration, a federal health agency said on Wednesday.

The price negotiation process was established under former President Joe Biden's signature Inflation Reduction Act (IRA) in 2022.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI